3rd Workshop: Biomedical Applications of Engineered Antibodies and Proteins
This free workshop will focus on the latest developments in antibody engineering across a variety of applications that include diagnostic/bioanalytical reagents and associated medical devices, imaging/theranostics, biologic medicines and targeted nanomedicines. This seminar workshop, run jointly by the ARC Training Centre for Biopharmaceutical Innovation, University of Queensland and the ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash University, will include presentations from invited experts from across the field.
Confirmed Speakers List
- Dr Trent Munro (AMGEN)
- Dr Evan Shave (Patheon Biologics)
- Dr Catherine Owczarek (CSL Ltd)
- Dr Melinda Dean (Australian Red Cross Blood Service)
- A/Prof Joanne Macdonald (University of the Sunshine Coast)
- Dr Douglas Campbell (Minomic International Ltd) Dr Simon Puttick (AIBN/CSIRO)
- Prof Peter Hudson (AVIPEP)
- Prof Kirill Alexandrov (Institute for Molecular Biosciences)
- Dr Tianlei Ying (Fudan University, Shanghai)
Register (for catering purposes)
Program
| TIME | SESSION DETAILS |
| 8:30AM | COFFEE & REGISTRATION (Speakers please load presentations for next session) |
| 9:15AM | Welcome from Prof Stephen Mahler and Dr Simon Corrie (Chairs) |
| 9:30AM | Dr Trent Munro (AMGEN) Challenges of developing multi-specific antibodies. |
| 10:00AM | Dr Catherine Owczarek (CSL Ltd) CSL311, a novel therapeutic mAb for the treatment of inflammatory diseases mediated by the common beta chain of the GM-CSF, IL-3 and IL-5 receptors. |
| 10:30AM | Dr Evan Shave (Patheon Biologics) Tech Transfer and Flexible Manufacturing of Biopharmaceuticals |
| 11:00AM | MORNING TEA (Speakers please load presentations for next session) |
| 11:30AM | Dr Tianlei Ying (Fudan University, Shanghai) Antibody-based therapeutics for the treatment of infectious diseases |
| 12:00PM | Prof Peter Hudson (Avipep) Antibody-directed cancer therapies; from drug-conjugate ADCs to CarTs (T-cell retargeting) |
| 12:30PM | Dr Melinda Dean (Australian Red Cross Blood Service) ENU mutagenesis as a tool for discovery of novel haematological phenotypes and a platform for antibody discovery |
| 1:00PM | LUNCH (Speakers please load presentations for next session) |
| 2:00PM | Dr Douglas Campbell (Minomic International Ltd) Development of anti-GPC-1 antibody therapeutics |
| 2:30PM | Prof Kirill Alexandrov (Institute for Molecular Biosciences) Using in vitro protein expression and AlphaLISA to rapidly validate and rank protein:protein interactions |
| 3:00PM | AFTERNOON TEA (Speakers please load presentations for next session) |
| 3:30PM | A/Prof Joanne Macdonald (University of the Sunshine Coast) Engineered bacterial enzymes for detoxification of cocaine and nerve agents in humans. |
| 4:00PM | Dr Simon Puttick (AIBN/CSIRO) mage guided physiologically based pharmacokinetic (PBPK) modelling of antibody and recombinant fragment theranostics) |
| 4:30PM | SOCIAL/NETWORKING |
This is a satellite event to the international conference on BioNano Innovation
About International Conference on BioNano Innovation
The intersection of Biology with Nanoscience and Nanotechnology currently represents one of the most exciting wellsprings of scientific innovation, and is also a major stimulus for a plethora of high value technologies and industries. By combining the two largest conferences in the world which focus on this scientific frontier, NanoBio Australia 2017 will feature a diverse array of multi-disciplinary science designed to connect world-leading scientists, engineers and entrepreneurs working in this space.